Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.05B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$404M |
| 3 |
AstraZeneca
AZN
|
+$342M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$288M |
| 5 |
Willis Towers Watson
WTW
|
+$227M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icahn Enterprises
IEP
|
+$641M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$538M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$294M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.22% |
| 2 | Financials | 7.52% |
| 3 | Healthcare | 6.46% |
| 4 | Consumer Discretionary | 6.41% |
| 5 | Communication Services | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Timken Company
TKR
$9.18B
| $3.14M | ﹤0.01% |
39,001
+2,521
| +7% | +$213K |
|
|
JOFF
2277
DELISTED
JOFF Fintech Acquisition Corp. Class A Common Stock
JOFF
| $3.14M | ﹤0.01% |
+324,999
| New | +$3.17M |
|
2278
iShares US Equity Factor ETF
LRGF
$3.68B
| $3.14M | ﹤0.01% |
73,209
+1,402
| +2% | +$59.3K |
|
2279
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.5B
| $3.13M | ﹤0.01% |
23,632
-1,097
| -4% | -$143K |
|
2280
Medifast
MED
$146M
| $3.13M | ﹤0.01% |
11,060
+4,281
| +63% | +$1.16M |
|
2281
CALL
Occidental Petroleum
OXY
$54.6B
| $3.13M | ﹤0.01% |
100,000
-100,000
| -50% | -$2.68M |
|
|
UCB
2282
United Community Banks
UCB
$4.33B
| $3.13M | ﹤0.01% |
97,697
+23,037
| +31% | +$776K |
|
|
ABMD
2283
PUT
DELISTED
Abiomed Inc
ABMD
| $3.12M | ﹤0.01% |
10,000
| – | – |
|
2284
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.28B
| $3.12M | ﹤0.01% |
30,066
-444
| -1% | -$45.4K |
|
|
TMX
2285
DELISTED
Terminix Global Holdings, Inc.
TMX
| $3.11M | ﹤0.01% |
65,271
+13,505
| +26% | +$663K |
|
2286
PUT
Zscaler
ZS
$25.9B
| $3.11M | ﹤0.01% |
14,400
| – | – |
|
2287
Cheesecake Factory
CAKE
$5.27B
| $3.1M | ﹤0.01% |
57,136
+25,392
| +80% | +$1.47M |
|
|
SAVE
2288
DELISTED
Spirit Airlines, Inc.
SAVE
| $3.08M | ﹤0.01% |
101,223
-382,875
| -79% | -$13.4M |
|
2289
Pricesmart
PSMT
$6.02B
| $3.07M | ﹤0.01% |
33,775
+7,622
| +29% | +$680K |
|
2290
Kemper
KMPR
$1.7B
| $3.07M | ﹤0.01% |
41,558
-161
| -0.4% | -$12.4K |
|
2291
Travere Therapeutics
TVTX
$5.13B
| $3.07M | ﹤0.01% |
210,519
+85,578
| +68% | +$1.69M |
|
2292
Korn Ferry
KFY
$4.21B
| $3.07M | ﹤0.01% |
42,294
+23,167
| +121% | +$1.54M |
|
2293
Skywest
SKYW
$4.54B
| $3.07M | ﹤0.01% |
71,230
+20,007
| +39% | +$986K |
|
2294
Helmerich & Payne
HP
$3.41B
| $3.07M | ﹤0.01% |
93,968
-25,698
| -21% | -$756K |
|
2295
Champion Homes
SKY
$4.6B
| $3.05M | ﹤0.01% |
57,260
+20
| +0% | +$943 |
|
|
IBTX
2296
DELISTED
Independent Bank Group, Inc.
IBTX
| $3.05M | ﹤0.01% |
41,259
+14,133
| +52% | +$1.07M |
|
2297
US Foods
USFD
$21.8B
| $3.05M | ﹤0.01% |
79,488
-125,181
| -61% | -$4.86M |
|
|
CANO
2298
DELISTED
Cano Health, Inc.
CANO
| $3.05M | ﹤0.01% |
+2,518
| New | +$3.4M |
|
2299
Cerence
CRNC
$418M
| $3.04M | ﹤0.01% |
28,461
-36,799
| -56% | -$3.62M |
|
2300
BioXcel Therapeutics
BTAI
$27.4M
| $3.03M | ﹤0.01% |
6,526
+1,080
| +20% | +$589K |
|
Similar funds
Citigroup's Q2 2021 Portfolio in Review
As of Q2 2021, Citigroup held 6,654 positions worth $166B, up 7.5% from $155B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2021 filing shows 397 new, 2,681 increased, 2,205 reduced and 444 closed positions. Its largest new stake was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M. The largest sale was Icahn Enterprises, an estimated $641M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2021 buy was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $2.05B increase.
- Citigroup's biggest Q2 2021 reduction was Icahn Enterprises, cutting an estimated $641M.
- Citigroup fully exited RealPage, Inc. in Q2 2021, selling an estimated $226M.
- Citigroup's ten largest holdings make up 20% of its $166B portfolio in Q2 2021.
- Citigroup opened 397 new positions and closed 444 in Q2 2021.
- Citigroup's portfolio value rose 7.5% quarter-over-quarter to $166B.
Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.